Rebecca Schennach-Wolff

Response and remission criteria in major depression – A validation of current practice

Michael Riedel, Hans‐Jürgen Möller, Michael Obermeier et al. · Journal of Psychiatric Research · 2010 · 286 citations

Nursing, Psychiatry, Clinical Psychology +15

Celecoxib treatment in an early stage of schizophrenia: Results of a randomized, double-blind, placebo-controlled trial of celecoxib augmentation of amisulpride treatment

Norbert Müller, Daniela Krause, Sandra Dehning et al. · Schizophrenia Research · 2010 · 255 citations

Medicine, Pharmacology, Pharmacotherapy +9

Should the PANSS Be Rescaled?

Michael Obermeier, Andreas Mayr, Rebecca Schennach-Wolff et al. · Schizophrenia Bulletin · 2009 · 126 citations · Full text

Social Sciences, Behavioral Sciences, Psychiatry +17

Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders

Rebecca Schennach-Wolff, Markus Jäger, Florian Seemüller et al. · Schizophrenia Research · 2009 · 120 citations

Medicine, Neuroscience, Psychiatry +14

Clinical predictors of response and remission in inpatients with depressive syndromes

Michael Riedel, Hans‐Jürgen Möller, Michael Obermeier et al. · Journal of Affective Disorders · 2011 · 80 citations

Social Sciences, Psychiatry, Psychology +14